-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $415

Benzinga·09/09/2026 18:03:51
语音播报
UBS analyst Doug Schenkel maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $340 to $415.